The association between anxiety disorders and in-hospital outcomes in patients with myocardial infarction.


Journal

Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 01 01 2020
revised: 04 03 2020
accepted: 09 03 2020
pubmed: 19 3 2020
medline: 26 5 2021
entrez: 19 3 2020
Statut: ppublish

Résumé

Anxiety disorders are prevalent in patients with myocardial infarction (MI), but the effects of anxiety disorders on in-hospital outcomes within MI patients have not been well studied. To examine the effects of concurrent anxiety disorders on in-hospital outcomes in MI patients. We conducted a retrospective cohort study in patients with a principal diagnosis of MI with and without anxiety disorders in the National Inpatient Sample 2016. A total of 129 305 primary hospitalizations for acute MI, 35 237 with ST-segment elevation myocardial infarction (STEMI), and 94 068 with non-ST elevation myocardial infarction (NSTEMI) were identified. Of these, 13 112 (10.1%) had anxiety (7.9% in STEMI and 11.0% in NSTEMI). We compared outcomes of anxiety and nonanxiety groups after propensity score matching for the patient and hospital demographics and relevant comorbidities. After propensity score matching, the anxiety group had a lower incidence of in-hospital mortality (3.0% vs 4.4%, P < .001), cardiac arrest (2.1% vs 2.8%, P < .001), cardiogenic shock (4.9% vs 5.6%, P = .007), and ventricular arrhythmia (6.7% vs 7.9%, P < .001) than the nonanxiety group. In the NSTEMI subgroup, the anxiety group had significantly lower rates of in-hospital mortality (2.3% vs 3.5%, P < .001), cardiac arrest (1.1% vs 1.5%, P = .008), and cardiogenic shock (2.8% vs 3.5%, P = .008). In the STEMI subgroup, we found no differences in in-hospital outcomes (all P > .05) between the matched groups. Although we found that anxiety was associated with better in-hospital outcomes, subgroup analysis revealed that this only applied to patients admitted for NSTEMI instead of STEMI.

Sections du résumé

BACKGROUND BACKGROUND
Anxiety disorders are prevalent in patients with myocardial infarction (MI), but the effects of anxiety disorders on in-hospital outcomes within MI patients have not been well studied.
HYPOTHESIS OBJECTIVE
To examine the effects of concurrent anxiety disorders on in-hospital outcomes in MI patients.
METHODS METHODS
We conducted a retrospective cohort study in patients with a principal diagnosis of MI with and without anxiety disorders in the National Inpatient Sample 2016. A total of 129 305 primary hospitalizations for acute MI, 35 237 with ST-segment elevation myocardial infarction (STEMI), and 94 068 with non-ST elevation myocardial infarction (NSTEMI) were identified. Of these, 13 112 (10.1%) had anxiety (7.9% in STEMI and 11.0% in NSTEMI). We compared outcomes of anxiety and nonanxiety groups after propensity score matching for the patient and hospital demographics and relevant comorbidities.
RESULTS RESULTS
After propensity score matching, the anxiety group had a lower incidence of in-hospital mortality (3.0% vs 4.4%, P < .001), cardiac arrest (2.1% vs 2.8%, P < .001), cardiogenic shock (4.9% vs 5.6%, P = .007), and ventricular arrhythmia (6.7% vs 7.9%, P < .001) than the nonanxiety group. In the NSTEMI subgroup, the anxiety group had significantly lower rates of in-hospital mortality (2.3% vs 3.5%, P < .001), cardiac arrest (1.1% vs 1.5%, P = .008), and cardiogenic shock (2.8% vs 3.5%, P = .008). In the STEMI subgroup, we found no differences in in-hospital outcomes (all P > .05) between the matched groups.
CONCLUSION CONCLUSIONS
Although we found that anxiety was associated with better in-hospital outcomes, subgroup analysis revealed that this only applied to patients admitted for NSTEMI instead of STEMI.

Identifiants

pubmed: 32187718
doi: 10.1002/clc.23358
pmc: PMC7298986
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

622-629

Informations de copyright

© 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.

Références

Medicine (Baltimore). 2016 Feb;95(6):e2815
pubmed: 26871852
Psychiatry Res. 2018 Aug;266:291-300
pubmed: 29615266
Chest. 2012 Jun;141(6):1441-1448
pubmed: 22207679
Biol Psychiatry. 2015 May 15;77(10):859-69
pubmed: 25433901
Health Serv Res. 2008 Aug;43(4):1424-41
pubmed: 18756617
J Am Coll Cardiol. 2010 Jul 20;56(4):254-63
pubmed: 20633817
Am J Cardiol. 1995 May 1;75(14):882-5
pubmed: 7732994
Psychol Med. 2008 Mar;38(3):375-83
pubmed: 17988419
Crit Care Nurs Clin North Am. 2019 Mar;31(1):49-64
pubmed: 30736935
Atherosclerosis. 2006 Apr;185(2):320-6
pubmed: 16005881
J Am Coll Cardiol. 2003 Nov 19;42(10):1801-7
pubmed: 14642691
Arq Bras Cardiol. 2018 Nov;111(5):676-683
pubmed: 30156607
J Psychosom Res. 2017 Feb;93:19-27
pubmed: 28107888
Stroke. 2017 Nov;48(11):2931-2938
pubmed: 29018137
Circulation. 1994 May;89(5):1992-7
pubmed: 8181122
J Psychosom Res. 2004 Oct;57(4):353-8
pubmed: 15518669
Arch Intern Med. 2004 Feb 23;164(4):440-6
pubmed: 14980996
Front Immunol. 2018 Sep 06;9:2031
pubmed: 30237802
Int J Cardiol. 2017 Jan 15;227:1-7
pubmed: 27846456
Psychother Psychosom. 2008;77(6):377-83
pubmed: 18716423
Circulation. 1993 Mar;87(3):893-9
pubmed: 7680290
Basic Res Cardiol. 2005 Sep;100(5):404-12
pubmed: 15965583
BMC Psychiatry. 2019 Apr 24;19(1):122
pubmed: 31014311
J Am Heart Assoc. 2017 Jul 20;6(7):
pubmed: 28729411
Prev Med. 2003 Jun;36(6):698-703
pubmed: 12744913
JAMA. 2000 Nov 22-29;284(20):2606-10
pubmed: 11086367
Psychosom Med. 2010 Jul;72(6):563-9
pubmed: 20410247
Br J Psychiatry. 2012 Apr;200(4):324-9
pubmed: 22403086
Clin Cardiol. 2020 Jun;43(6):622-629
pubmed: 32187718
Psychosom Med. 2016 Jun;78(5):593-601
pubmed: 27136495
JAMA. 2011 Nov 16;306(19):2120-7
pubmed: 22089719
J Am Coll Cardiol. 2000 Aug;36(2):643-50
pubmed: 10933383
J Am Coll Cardiol. 2015 Sep 1;66(9):1083-4
pubmed: 26314538
Am J Cardiol. 2001 May 1;87(9):1039-44
pubmed: 11348599

Auteurs

Pengyang Li (P)

Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA.

Xiaojia Lu (X)

Department of Cardiology, the First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.

Mark Kranis (M)

Department of Cardiology, Saint Vincent Hospital, Worcester, Massachusetts, USA.

Fangcheng Wu (F)

Department of Medicine, Memorial Hospital West, Pembroke Pines, Florida, USA.

Catherine Teng (C)

Department of Medicine, Greenwich Hospital, Yale New Haven Health, Greenwich, Connecticut, USA.

Peng Cai (P)

Department of Mathematical Sciences, Worcester Polytechnic Institute, Worcester, Massachusetts, USA.

Zeba Hashmath (Z)

Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA.

Bin Wang (B)

Department of Cardiology, the First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH